Full Length Research Articles
1. Mitra A, Datta R, Rana S, Sarkar S. (2017) Modulation of NFKB1/p50 by ROS leads to impaired ATP production during MI compared to cardiac hypertrophy. Journal of Cellular Biochemistry. doi: 10.1002/jcb.26318 (Online ISSN: 1097-4644; Impact Factor: 3.085). PubMed
2. Ray A , Rana S, Banerjee D , Mitra A , Datta R, Naskar S, Sarkar S. (2015) Improved bioavailability of targeted Curcumin delivery efficiently regressed cardiac hypertrophy by modulating apoptotic load within cardiac microenvironment. Toxicology and Applied Pharmacology 290 (2016) 54–65. doi:10.1016/j.taap.2015.11.011. [Online ISSN:0041-008X ; Impact Factor:3.8] PubMed
3. Mitra A, Basak T, Ahmad S, Datta K, Datta R, Sengupta S, Sarkar S. (2014) Comparative Proteome Profiling during Cardiac Hypertrophy and Myocardial Infarction Reveals Altered Glucose Oxidation by Differential Activation of Pyruvate Dehydrogenase E1 Component Subunit β. J Mol Biol. 2014 Nov 8. pii: S0022-2836(14)00581-6. doi: 10.1016/j.jmb.2014.10.026. [Online ISSN:0022-2836 ; Impact Factor:4 .63] PubMed
4. Naskar S, Datta K, Mitra A, Pathak K, Datta R, Bansal T, Sarkar S. (2014) Differential and conditional activation of PKC-isoforms dictates cardiac adaptation during physiological to pathological hypertrophy. PLoS One. 9(8): e104711, doi:10.1371/journal.pone.0104711. [Online ISSN: 1932-6203; Impact Factor: 2.81] PubMed
5. Mitra A, Ray A, Datta R, Sengupta S, Sarkar S. (2014) Cardioprotective role of P38 MAPK during myocardial infarction via parallel activation of α-crystallin B and Nrf2. J Cell Physiol. 229(9):1272-82. [Online ISSN: 1097-4652 ; Impact Factor: 4.08] PubMed
6. Mitra A, Basak T, Datta K, Naskar S, Sengupta S , Sarkar S. (2013) Role of α-crystallin B as a regulatory switch in modulating cardiomyocyte apoptosis by mitochondria or endoplasmic reticulum during cardiac hypertrophy and myocardial infarction. Cell Death and Disease. 4:e582. [Online ISSN: 2041-4889; Impact Factor: 5.97] PubMed
7. Mir SA, Chatterjee A, Mitra A, Pathak K, Mahata SK, Sarkar S. (2012) Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart. J Biol Chem. 287(4):2666-77.[Online ISSN: 1083-351X; Impact Factor: 4.13] PubMed
8. Chatterjee A, Mir SA, Dutta D, Mitra A, Pathak K, Sarkar S. (2011) Analysis of p53 and NF-κB signaling in modulating the cardiomyocyte fate during hypertrophy. J Cell Physiol. 226(10):2543-54. [Online ISSN: 1097-4652 ; Impact Factor: 4.08] PubMed
Review Articles
1. Gupta S, Mitra A*. (2021) Challenge of post-COVID era: management of cardiovascular complications in asymptomatic carriers of SARS-CoV-2. Heart Fail Rev . doi: 10.1007/s10741-021-10076-y. [Online ISSN: 1573-7322; Impact Factor: 3.538]
2. Gupta S, Mitra A*. (2020) Heal the heart through gut (hormone) ghrelin: a potential player to combat heart failure. Heart Fail Rev . doi: 10.1007/s10741-020-10032-2. [Online ISSN: 1573-7322; Impact Factor: 3.538] PubMed
3. Ganguly S, Mitra A, Sarkar S. (2014) Role of α-Crystallin B in Regulation of Stress Induced Cardiomyocyte Apoptosis. Cardiovasc Hematol Agents Med Chem. 12: 60-65 [Online ISSN: 1875-6182 ; Impact Factor: NA] PubMed
Mini Articles/Abstracts
1. Mitra A, Datta K, Sarkar S. (2014) Role of alpha crystallin B in regulation of differential mechanism of myocyte cell death during heart failure. Heart. 100 Suppl 1:A8. doi: 10.1136/heartjnl-2013-305297.21. [Online ISSN: 1468-201X ; Impact Factor: 6.059] Abstract
2. Mitra A, Basak T, Sengupta S, Sarkar S. (2012) Myocyte Apoptosis Occurs Via Different Routes in Etiologically Different Cardiac Diseases. Journal of Hypertension. 30(e-Supplement 1): e233. doi: 10.1097/01.hjh.0000420425.36437.10. [Online ISSN: 1473-5598 ; Impact Factor: 4.085] Abstract
(Corresponding author indicated with *)
Reference: 2019 Journal Citation Reports® Science Edition(Thomson Reuters, 2020)